Clinical Trials Directory

Trials / Completed

CompletedNCT04804787

Emotions in Multiple Sclerosis

Emotions Recognition in Multiple Sclerosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
101 (actual)
Sponsor
Lille Catholic University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

Through this study, a group composed of multiple sclerosis patients will be compared to a healthy volunteers group to determine if the positive emotions recognitions is preserved in the first group.

Detailed description

Different studies have highlighted the specific deficiency concerning emotions recognition in multiple sclerosis. Patients with multiple sclerosis are reported to have more difficulty recognising negative emotions, especially anger and fear. In this context, RECODE study has a twofold objective: * To determine whether the positive emotions recognition remains preserved by combining behavioural and neurophysiological measures (electrodermal activity). * To study this disorder's etiology through a comparison between a multiple sclerosis patient group and a control group (matched in sex, age, and education's level).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCarrying out a tests and questionnaires batteryThe attendees will carry out different questionnaires and tests to evaluate their potential cognitive disorders

Timeline

Start date
2021-06-23
Primary completion
2025-02-25
Completion
2025-02-25
First posted
2021-03-18
Last updated
2025-12-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04804787. Inclusion in this directory is not an endorsement.